• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将冠心病患者的临床结局测量指标和人口统计学变量与 EQ-5D 指数进行映射。

Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.

机构信息

Papworth Hospital NHS Trust, Cambridge, UK.

出版信息

Health Qual Life Outcomes. 2010 Jun 4;8:54. doi: 10.1186/1477-7525-8-54.

DOI:10.1186/1477-7525-8-54
PMID:20525323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2900231/
Abstract

BACKGROUND

The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D may not be gathered. This study aimed to assess whether demographic and clinical outcome variables, including scores from a disease specific measure, the Seattle Angina Questionnaire (SAQ), could be used to predict, or map, the EQ-5D index value where it is not available.

METHODS

Patient-level data from 5 studies of cardiac interventions were used. The data were split into two groups - approximately 60% of the data were used as an estimation dataset for building models, and 40% were used as a validation dataset. Forward ordinary least squares linear regression methods and measures of prediction error were used to build a model to map to the EQ-5D index. Age, sex, a proxy measure of disease stage, Canadian Cardiovascular Society (CCS) angina severity class, treadmill exercise time (ETT) and scales of the SAQ were examined.

RESULTS

The exertional capacity (ECS), disease perception (DPS) and anginal frequency scales (AFS) of the SAQ were the strongest predictors of the EQ-5D index and gave the smallest root mean square errors. A final model was chosen with age, gender, disease stage and the ECS, DPS and AFS scales of the SAQ. ETT and CCS did not improve prediction in the presence of the SAQ scales. Bland-Altman agreement between predicted and observed EQ-5D index values was reasonable for values greater than 0.4, but below this level predicted values were higher than observed. The 95% limits of agreement were wide (-0.34, 0.33).

CONCLUSIONS

Mapping of the EQ-5D index in cardiac patients from demographics and commonly measured cardiac outcome variables is possible; however, prediction for values of the EQ-5D index below 0.4 was not accurate. The newly designed 5-level version of the EQ-5D with its increased ability to discriminate health states may improve prediction of EQ-5D index values.

摘要

背景

EuroQoL 5D(EQ-5D)是一种用于成本效益分析的效用衡量工具。EQ-5D 已广泛应用于许多患者群体,包括冠心病患者。研究通常需要患者完成许多问卷,而 EQ-5D 可能无法收集。本研究旨在评估人口统计学和临床结果变量,包括特定疾病量表西雅图心绞痛问卷(SAQ)的评分,是否可用于预测或映射无法获得的 EQ-5D 指数值。

方法

使用 5 项心脏介入研究的患者水平数据。数据分为两组 - 约 60%的数据用于构建模型的估计数据集,40%的数据用于验证数据集。使用正向普通最小二乘线性回归方法和预测误差测量方法构建模型以映射到 EQ-5D 指数。评估年龄、性别、疾病阶段的替代指标、加拿大心血管学会(CCS)心绞痛严重程度分级、跑步机运动时间(ETT)和 SAQ 量表。

结果

SAQ 的运动能力(ECS)、疾病感知(DPS)和心绞痛频率量表(AFS)是 EQ-5D 指数的最强预测指标,其均方根误差最小。选择了一个包含年龄、性别、疾病阶段以及 SAQ 的 ECS、DPS 和 AFS 量表的最终模型。在存在 SAQ 量表的情况下,ETT 和 CCS 并不能提高预测能力。对于大于 0.4 的 EQ-5D 指数值,预测值与观察值之间的 Bland-Altman 一致性是合理的,但低于该水平时,预测值高于观察值。95%的一致性界限较宽(-0.34,0.33)。

结论

从人口统计学和常用的心脏结局变量映射心脏患者的 EQ-5D 指数是可行的;然而,对于 EQ-5D 指数低于 0.4 的值,预测并不准确。新设计的 5 级 EQ-5D 具有更高的区分健康状态的能力,可能会提高 EQ-5D 指数值的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/2900231/570ebf944a72/1477-7525-8-54-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/2900231/1c06b6695bec/1477-7525-8-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/2900231/570ebf944a72/1477-7525-8-54-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/2900231/1c06b6695bec/1477-7525-8-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/2900231/570ebf944a72/1477-7525-8-54-2.jpg

相似文献

1
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.将冠心病患者的临床结局测量指标和人口统计学变量与 EQ-5D 指数进行映射。
Health Qual Life Outcomes. 2010 Jun 4;8:54. doi: 10.1186/1477-7525-8-54.
2
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.EQ-5D 指数与心血管干预研究中部分临床结局测量指标之间的关系。
Health Qual Life Outcomes. 2009 Nov 26;7:96. doi: 10.1186/1477-7525-7-96.
3
Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework.基于贝叶斯框架的映射算法:从冠状动脉疾病西雅图心绞痛问卷预测 EQ-5D 效用评分。
Med Decis Making. 2011 May-Jun;31(3):481-93. doi: 10.1177/0272989X10386800. Epub 2010 Dec 2.
4
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.将 ALSFRS-R 和 ALSUI 与运动神经元病患者的 EQ-5D 进行映射。
Value Health. 2018 Nov;21(11):1322-1329. doi: 10.1016/j.jval.2018.05.005. Epub 2018 Jul 26.
5
Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.将SRS-22r问卷映射到青少年特发性脊柱侧凸患者的EQ-5D-5L效用评分上。
PLoS One. 2017 Apr 17;12(4):e0175847. doi: 10.1371/journal.pone.0175847. eCollection 2017.
6
Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.利用韩国关节炎观察研究网络(KORONA)登记数据,将健康评估问卷残疾指数(HAQ-DI)评分、疼痛视觉模拟量表(VAS)以及28个关节疾病活动评分(DAS28)映射到欧洲五维度健康量表(EQ-5D)效用评分上。
Rheumatol Int. 2016 Apr;36(4):505-13. doi: 10.1007/s00296-016-3427-1. Epub 2016 Feb 6.
7
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.使用多种建模方法将 FACT-B 映射到 EQ-5D-5L:来自中国乳腺癌患者的数据。
Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8.
8
Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease.将西雅图心绞痛问卷(SAQ)映射到冠心病患者的 EQ-5D-5L 量表中。
Health Qual Life Outcomes. 2023 Jul 3;21(1):64. doi: 10.1186/s12955-023-02151-9.
9
Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.稳定型心绞痛患者中欧洲五维度健康量表(EQ - 5D)与简短健康调查简表6维度(SF - 6D)的验证与比较
Health Qual Life Outcomes. 2014 Oct 25;12:156. doi: 10.1186/s12955-014-0156-6.
10
Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.将癌症特异性 EORTC QLQ-C30 映射到偏好加权 EQ-5D、SF-6D 和 15D 工具。
Value Health. 2009 Nov-Dec;12(8):1151-7. doi: 10.1111/j.1524-4733.2009.00569.x. Epub 2009 Jun 25.

引用本文的文献

1
Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and protocol for a multicentre randomised controlled trial - REACH-HFpEF trial.射血分数保留的心力衰竭患者及其照护者的慢性心力衰竭康复赋能促进自我护理康复干预的临床有效性和成本效益:一项多中心随机对照试验(REACH-HFpEF试验)的原理和方案
BMJ Open. 2025 May 27;15(5):e094254. doi: 10.1136/bmjopen-2024-094254.
2
Cost-effectiveness of Fractional Flow Reserve Versus Intravascular Ultrasound to Guide Percutaneous Coronary Intervention: Results From the FLAVOUR Study.血流储备分数与血管内超声指导经皮冠状动脉介入治疗的成本效益:FLAVOUR研究结果
Korean Circ J. 2025 Jan;55(1):34-46. doi: 10.4070/kcj.2024.0156. Epub 2024 Oct 11.
3

本文引用的文献

1
A review of health utilities using the EQ-5D in studies of cardiovascular disease.使用 EQ-5D 在心血管疾病研究中评估健康效用。
Health Qual Life Outcomes. 2010 Jan 28;8:13. doi: 10.1186/1477-7525-8-13.
2
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.EQ-5D 指数与心血管干预研究中部分临床结局测量指标之间的关系。
Health Qual Life Outcomes. 2009 Nov 26;7:96. doi: 10.1186/1477-7525-7-96.
3
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.
Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease.将西雅图心绞痛问卷(SAQ)映射到冠心病患者的 EQ-5D-5L 量表中。
Health Qual Life Outcomes. 2023 Jul 3;21(1):64. doi: 10.1186/s12955-023-02151-9.
4
Association Between Myasthenia Gravis-Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities.重症肌无力日常生活活动(MG-ADL)与 EQ-5D-5L 效用值之间的关联:依库珠单抗对效用的附加影响。
Adv Ther. 2023 Apr;40(4):1818-1829. doi: 10.1007/s12325-023-02437-w. Epub 2023 Mar 3.
5
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease.一次性心血管疾病预防筛查采用统一标准与基于年龄标准的成本效益比较。
Eur J Health Econ. 2023 Sep;24(7):1033-1045. doi: 10.1007/s10198-022-01533-y. Epub 2022 Oct 14.
6
Review of Systematic Reviews in the Field of Telemedicine.远程医疗领域系统评价的综述
Med J Islam Repub Iran. 2021 Dec 29;35:184. doi: 10.47176/mjiri.35.184. eCollection 2021.
7
Health-related quality of life following percutaneous coronary intervention during the COVID-19 pandemic.新冠肺炎疫情期间经皮冠状动脉介入治疗后的健康相关生活质量。
Qual Life Res. 2022 Aug;31(8):2375-2385. doi: 10.1007/s11136-021-03056-0. Epub 2022 Jan 3.
8
Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction.与射血分数降低的心力衰竭患者相比,射血分数保留的心力衰竭患者的心理社会因素、心理健康和协调能力。
ESC Heart Fail. 2021 Aug;8(4):3268-3278. doi: 10.1002/ehf2.13468. Epub 2021 Jun 13.
9
Patient-Reported Outcomes in Cardiovascular Trials.心血管临床试验中的患者报告结局。
Can J Cardiol. 2021 Sep;37(9):1340-1352. doi: 10.1016/j.cjca.2021.04.006. Epub 2021 May 8.
10
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure.预测心力衰竭患者的 EQ-5D 效用值来自堪萨斯城心肌病问卷。
Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):388-396. doi: 10.1093/ehjqcco/qcab014.
对基于非偏好的健康衡量指标与通用偏好为基础的衡量指标进行映射(或交叉比对)的研究综述。
Eur J Health Econ. 2010 Apr;11(2):215-25. doi: 10.1007/s10198-009-0168-z. Epub 2009 Jul 8.
4
Comparing the standard EQ-5D three-level system with a five-level version.将标准的EQ-5D三级系统与五级版本进行比较。
Value Health. 2008 Mar-Apr;11(2):275-84. doi: 10.1111/j.1524-4733.2007.00230.x.
5
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.功能性心脏检查在冠状动脉疾病诊断和管理中的成本效益:一项随机对照试验。CECaT试验。
Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115. doi: 10.3310/hta11490.
6
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.关于心绞痛替代治疗临床适宜决策的成本效益:前瞻性观察性研究
BMJ. 2007 Mar 24;334(7594):624. doi: 10.1136/bmj.39129.442164.55. Epub 2007 Mar 5.
7
Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.癌症患者中标准EQ - 5D与5级版本的心理测量学比较。
Med Care. 2007 Mar;45(3):259-63. doi: 10.1097/01.mlr.0000254515.63841.81.
8
Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK).英国心室辅助装置使用的成本效益:英国心室辅助装置项目评估(EVAD-UK)的结果
J Heart Lung Transplant. 2006 Nov;25(11):1336-43. doi: 10.1016/j.healun.2006.09.011.
9
An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial.一项关于难治性心绞痛患者脊髓刺激与经皮心肌激光血运重建术的开放标签、单中心随机试验:SPiRiT试验
Eur Heart J. 2006 May;27(9):1048-53. doi: 10.1093/eurheartj/ehi827. Epub 2006 Mar 22.
10
Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.通过反应映射估计SF-12反应与EQ-5D效用值之间的关联。
Med Decis Making. 2006 Jan-Feb;26(1):18-29. doi: 10.1177/0272989X05284108.